Эволюция технологий защиты миокарда при кардиохирургических вмешательствах

Бесплатный доступ

Короткий адрес: https://sciup.org/140225830

IDR: 140225830

Список литературы Эволюция технологий защиты миокарда при кардиохирургических вмешательствах

  • Бокерия, Л.А. Защита миокарда при операциях аортокоронарного шунтирования/Л.А. Бокерия, Э.Д. Нисневич, А.В. Лушкин и др.//Грудная и серд.-сосуд. хир. -2000. -№ 4. -С. 29-31.
  • Бокерия Л.А., Бекназарян Д.Ю., Нисневич Э.Д., Мовсесян Р.Р., Самуилова Д.Ш., Алшибая М.Д. Сравнительная характеристика эффективности защиты миокарда при операциях аортокоронарного шунтирования//Грудная и серд.-сосуд. хир. -2007. -№ 3. -С. 19-22.
  • Искусственное кровообращение в хирургии сердца и магистральных сосудов/под ред. действ. чл. АМН СССР проф. П.А. Куприянова. -Л.: Медгиз, 1962. -304 с.
  • Кецкало, М.В. Интраоперационная защита миокарда с помощью тепловой кардиоплегии на основе аутокрови при операциях прямой реваскуляризации миокарда в условиях искусственного кровообращения//ВМЖ. -2004. -Т. 325, № 7. -С. 40-41.
  • Малашенков, А.И. Сравнительная оценка защиты миокарда при операциях с искусственным кровообращением: Автореф. дис.. д-ра мед. наук. -М., 1982. -47 с.
  • Немытин, Ю.В. Возможности кровяной фармакохолодовой кардиоплегии при длительных сроках пережатия аорты//ВМЖ. -2003. -Т. 324, № 3. -С. 70.
  • Немытин, Ю.В. Интраоперационная защита миокарда с помощью кровяной фармакохолодовой кардиоплегии при аортокоронарном шунтировании//ВМЖ. -2003. -Т. 324, № 4. -С. 59-60.
  • Чичерина, Н.И. Защита миокарда при выполнении коронарного шунтирования с использованием модифицированной методики кардиоплегии раствором Кустодиол/Н.И. Чичерина, И.Н. Чичерин, А.С. Редикульцев, В.Р. Пинегин//Медицинский альманах. -2013. -№ 4 (28). -С. 42-45.
  • Шаталов, А.Е. Кардиоплегия на основе крови. Современное состояние и перспективы развития//Вестник хирургии им. И.И. Грекова. -2004. -№ 5. -С. 128-131.
  • Шевченко, Ю.Л. Защита миокарда при операциях на сердце. Л.: 1993. -183 с.
  • Шевченко, Ю.Л. Применение интермиттирующей тепловой кровяной калиевой кардиоплегии у больных с ишемической болезнью сердца/ЮЛ. Шевченко, И.А. Борисов, Ю.И. Гороховатский и др.//Тез. докл. 7-го Всерос. съезда серд.-сосуд. хирургов. -М., НЦ ССХ им. А.Н. Бакулева, 2001. -С. 178.
  • Allen, P., and Lillehei, C.W. (1957). Use of induced cardiac arrest in open heart surgery; results in seventy patients. Minn. Med. 40, 672-676.
  • Arslan, A., Sezgin, A., Gultekin, B., et al. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection. Transplant Proc 2005; 37: 3219-22.
  • Beyersdorf F., Krause E., Sarai K., et al. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery. Thorac Cardiovasc Surg 1990; 38: 20-9.
  • Bjork, V.O., and Fors, B. (1961). Induced cardiac arrest. J. Thorac. Cardiovasc. Surg. 41,387-394.
  • Bootie, T., Vida, V., Padalino, M., Gerosa, G., Stellin, G. Early and long-term prognostic value of Troponin-I after cardiac surgery in newborns and children. Eur J Cardiothorac Surg. 2006; 30: 250-255.
  • Boros, D. Custodiol versus blood cardioplegia: comparison of myocardial protection in adult cardiac cases/The University of Arizona Library. http://hdl.handle.net/10150/311 -551.
  • Braathen, B., Jeppsson, A., Scherstén, H., et al. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg 2011; 141: 995-1001.
  • Braathen, B., T0nnessen, T. Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis. J Thorac Cardiovasc Surg. 2010; 139: 874-880.
  • Bretschneider, H.J., Huubner, G., and Knoll, D. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J. Cardiovasc. Surg. 1975. 16, 241-260.
  • Buckberg, G.D. (1993). Myocardial protection: an overview. Semin. Thorac. Cardiovasc. Surg. 5, 98-106.
  • Burgen, AS.V., and Terroux, K.G. (1953). The membrane resting and action potentials of the cat auricle. J. Physiol. 119, 139-152.
  • Careaga, G., Salazar, D., Téllez, S., et al. Clinical impact of histidine-ketoglutaratetryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. Arch Med Res 2001; 32:2 96-9.
  • Carrier, M., Tourigny, A., Thoribé, N., Montpetit, M., Khalil, A., Solymoss, B.C., Pelletier, L.C. Effects of cold and warm blood cardioplegia assessed by myocardial pH and release of metabolic markers. Ann Thorac Surg. 1994; 58: 764-767.
  • Chambers, D.J., and Hearse, D.J. (2001). "Cardioplegia and Surgical Ischaemia," in Heart Physiology and Pathophysiology, eds N. Sperelakis, Y. Kurachi, A. Terzic, and M. V. Cohen (San Diego, CA: Academic Press), 887-926. 9/50053-5 DOI: 10.1016/B978-012656975-
  • Cooley, D.A., Reul, G.JJ., and Wukasch, D.C. (1975). Ischemic myocardial contracture ("stone heart"). A complication of cardiac surgery. Isr. J. Med. Sci. 11,203-210.
  • Cordell, A.R. (1995). Milestones in the development of cardioplegia. Ann. Thorac. Surg. 60, 793-796 DOI: 10.1016/0003-4975(95)00570-B
  • Del Nido, P., Wilson, G., Mickle, D., Bush, B., Rebeyka, I., Klement P., et al. The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment, J Thorac Cardiovasc Surg, 1985, Vol. 89 (pg. 689-99).
  • Del Nido, P.J., Mickle, D.A., Wilson, G.J., Benson, L.N., Weisel, R.D., Coles, J.G., Trusler, G.A., Williams, W.G. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1988; 95: 223-229.
  • Demmy, T.L., Molina, J.E., Ward, H.B., et al. Custodiol versus Plegisol: A phase 3 multicentre myocardial protection study. Int J Angiol 2008; 17: 149-53.
  • Dobson, G.P. (2010). Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery (editorial -free standing). J. Thorac. Cardiovasc. Surg. 140, 1213-1217. 2010.05.040 DOI: 10.1016/j.jtcvs
  • Draper, M.H., and Weidmann, S (1951). Cardiac resting and action potentials recorded with an intracellular electrode. J. Physiol. 115, 74-94.
  • Edelman, J.J., Seco, M., Dunne, B., et al. Systematic review protocol: single-dose histidine-tryptophan-ketoglutarate vs. intermittent crystalloid or blood cardioplegia. Ann Cardiothorac Surg 2013; 2: 677.
  • Effler, D.B., Groves, L.K., Sones, F.M.J., and Kolff, W.J. (1956). Elective cardiac arrest in open-heart surgery; report of three cases. Cleve. Clin. Q. 23, 105-114 DOI: 10.3949/ccjm.23.2.105
  • Fan, Y., Zhang, A.M., Xiao, Y.B., Weng, Y.G., Hetzer, R. Warm versus cold cardioplegia for heart surgery: a meta-analysis. Eur J Cardiothorac Surg. 2010;37:912-919.
  • Fannelop, T., Dahle, G.O., Salminen, P.R., et al. Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig. Ann Thorac Surg 2009; 87: 1205-13.
  • Ferguson, Z.G. Evidence-based medicine and myocardial protection-where is the evidence?//Perfusion. -2015. -Vol. 30, Issue 5, 415-422.
  • Gallandat Huet, R.C., Karliczek, G.F., van der Heide, J.N., et al. Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system. Thorac Cardiovasc Surg 1988; 36: 151-6.
  • Gaudino, M., Pragliola, C., Anselmi, A., et al. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery. Scand Cardiovasc J. 2013 .
  • Gay, W.A., and Ebert, P.A. (1973). Functional, metabolic, and morphological effects of potassium induced cardioplegia. Surgery 74, 284-290.
  • Gerbode, F., and Melrose, D.G. (1958). The use of potassium arrest in open cardiac surgery. Am. J. Surg. 96, 221-227 DOI: 10.1016/0002-9610(58)90906-1
  • Guru, V., Omura, J., Alghamdi, A.A., Weisel, R., Fremes, S.E. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006; 114: 1331-1338.
  • Hachida, M., Nonoyama, M., Bonkohara, Y., et al. Clinical assessment of prolonged myocardial preservation for patients with a severely dilated heart. Ann Thorac Surg 1997; 64: 59-63
  • Hearse, D.J., and Stewart, D.A. Functional recovery of the myocardium after elective cardiac arrest in the isolated rat heart. Lancet 1974. 9, 192-194. 6736(74)92495-7 DOI: 10.1016/S0140-
  • Hearse, D.J., Braimbridge, M.V., and Jynge, P. (1981). "Principles of Cardioplegia," in Protection of the Ischaemic Myocardium: Cardioplegia, eds D.J. Hearse, M.V. Braimbridge, and P. Jynge (New York, NY: Raven Press), 151-326.
  • Helmsworth, J.A., Kaplan, A., Clark, L.C.J., McAdams, A.J., Mathews, E.C., and Edwards, F.K. (1959). Myocardial injury associated with asystole induced with potassium citrate. Ann. Surg. 149, 200-206 DOI: 10.1097/00000658-195902000-00005
  • Hering, H.E. (1953). Quoted by Wiggers, CJ Defibrillation of the ventricles. Circ. Res. 1, 191-199.
  • Hoelscher, B. (1967). Studies by electron microscopy on the effects of magnesium chloride-procaine amide or potassium citrate on the myocardium in induced cardiac arrest. J. Cardiovasc. Surg. (Torino). 8, 163-166.
  • Hoffman, B.F. (2002). And then came the microelectrode. Cardiovasc. Res. 53, 1-5 DOI: 10.1016/S0008-6363(01)00502-8
  • Immer, F.F., Stocker, F., Seiler, A.M., Pfammatter J.P., Bachmann D, Printzen G, Carrel T. Troponin-I for prediction of early postoperative course after pediatric cardiac surgery. J Am Coll Cardiol. 1999; 33: 1719-1723.
  • Immer, F.F., Stocker, F.P., Seiler, A.M., Pfammatter, J.P., Printzen, G., Carrel, T.P. Comparison of troponin-I and troponin-T after pediatric cardiovascular operation. Ann Thorac Surg. 1998;66:2073-2077.
  • Jeppsson, A., Schersten, H., Hagen, O.M., Vengen, O., Rexius, H., et al. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. The Journal of Thoracic and Cardiovascular Surgery. 2011; 141(4): 995-1001.
  • Kammerer, I., Nagib, R., Hipp, G., et al. Myocardial Protection in Minimally Invasive Mitral Valve Surgery: Comparison of the Cold-Blood Cardioplegia of the Bretschneider Solution and the Warm-Blood Cardioplegia of the Calafiore Protocol. Arch Clin Exp Surg 2012; 1: 14-21.
  • Kirklin, J.W., Conti, V.R., and Blackstone, E.H. (1979). Prevention of myocardial damage during cardiac operations. N. Engl. J. Med. 301, 135-141. 197907193010305 DOI: 10.1056/NEJM-
  • Kirsch, U., Rodewald, G., and Kalmar, P. (1972). Induced ischemic arrest: clinical experience with cardioplegia in open-heart surgery. J. Thorac. Cardiovasc. Surg. 63, 121-130.
  • Kresh, J., Nastala, C., Bianchi, P., Goldman, S., Brockman, S. The relative buffering power of cardioplegic solutions, J Thorac Cardiovasc Surg, 1987, Vol. 93 (pg. 309-11).
  • Lam, C.R., Geoghegan, T., and Lepore, A. (1955). Induced cardiac arrest for intracardiac surgical procedures; an experimental study. J. Thorac. Surg. 30, 620-625.
  • Lam, C.R., Gahagan, T., Sergant, C., and Green, E. (1957). Clinical experiences with Induced cardiac arrest during intracardiac surgical procedures. Ann. Surg. 146, 439-449.
  • Magovern, G.J., Dixon, C.M., Burkholder, J.A. Improved myocardial protection with nifedipine and potassium-based cardioplegia. J Thorac Cardiovasc Surg. 1981; 82: 239-244. .
  • Melrose, D.G., Dreyer, B., Bentall, H.H., and Baker, J.B.E. (1955). Elective cardiac arrest. Lancet 2, 21-22 DOI: 10.1016/S0140-6736(55)93381-X
  • Melrose, D.G. The first 25 years of cardioplegia/Proceedings Symposium Cardioplegia: The First Quarter Century, London June 1980. P 1-5.
  • Mentzer, R.M.J., Jahania, M.S., and Lasley, R.D. (2003). "Myocardial protection," in Cardiac Surgery in the Adult, 2nd Edn., eds LH Cohn and LHJ Edmunds (New York, NY: McGraw-Hill), 413-438.
  • Niedergerke, R. (1956). The potassium chloride contracture of the heart and its modification by calcium. J. Physiol. 134, 584-599.
  • Nunn, D.D., Belisle, C.A., Lee, W.H. Jr., and Parker, E.F. (1959). A comparative study of aortic occlusion alone and of potassium citrate arrest during cardiopulmonary bypass. Surgery 45, 848-851.
  • Saitoh, Y. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function, Ann Thorac Surg, 2000, Vol. 69 (pg. 107-12).
  • Sakata, J., Morishita, K., Ito, T., et al. Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement. J Card Surg 1998; 13:43-7.
  • Savini, C., Camurri, N., Castelli, A., Dell'Amore, A., Pacini, D., Suarez, S.M., et al. Myocardial protection using HTK solution in minimally invasive mitral valve surgery. The Heart Surgery Forum. 2005; 8(1): E25-7.
  • Schaff, H.V., Dombroff, R., Flaherty, J.T., Bulkley, B.H., Hutchins, G.M., Goldman, R.A., et al. (1978). Effect of potassium cardioplegia on myocardial ischemia and post arrest ventricular function. Circulation 58, 240-249 DOI: 10.1161/01.CIR.58.2.240
  • Schaper, J., Scheld, H., Schmidt, U., Hehrlein, F. Ultrastructural study comparing the efficacy of five different methods of intraoperative myocardial protection in the human heart, J Thorac Cardiovasc Surg, 1986, Vol. 92 (pg. 47-55).
  • Scrascia, G., Guida, P., Rotunno, C., et al. Myocardial protection during aortic surgery: comparison between Bretschneider-HTK and cold blood cardioplegia. Perfusion 2011; 26: 427-33.
  • Shiroishi, M.S. (1999). Myocardial protection: the rebirth of potassium-based cardioplegia. Tex. Heart Inst. J. 26, 71-86.
  • Shumway, N.E., Lower, R.R., and Stofer, R.C. (1959). Selective hypothermia of the heart in anoxic cardiac arrest. Surg. Gynecol. Obstet. 104, 750-756.
  • Sunderdiek, U., Feindt, P., Gams, E. Aortocoronary bypass grafting: a comparison of HTK cardioplegia vs. intermittent aortic cross-clamping. European Journal of CardioThoracic Surgery. 2000; 18(4): 393-9.
  • Takeuchi, K., Akimoto, H., Maida, K., Munakata, M., Fukui, K., Daitoku, K., et al. Myocardial protection of the pressure overload hypertrophied heart in human cardiac surgery by acceleration of anaerobic glycolysis, J Cardiovasc Surg (Torino), 2002, Vol. 43 (pg. 37-41).
  • Tyers, G.F., Todd, G.J., Niebauer, I.M., Manley, N.J., and Waldhausen, J.A. (1975). The mechanism of myocardial damage following potassium citrate (Melrose) cardioplegia. Surgery 78, 45-53.
  • Urschel, H. C. J., Greenberg, J. J., and Hufnagel, C. A. (1959). Elective cardioplegia by local cardiac hypothermia. N. Engl. J. Med. 261,1330-1332. 195912242612607 DOI: 10.1056/NEJM-
  • Viana, F.F., Shi, W.Y., Hayward, P.A., et al. Custodiol versus blood cardioplegia in complex cardiac operations: an Australian experience. Eur J Cardiothorac Surg 2013; 43: 526-31.
  • Vinten-Johansen, J., Ronson, R.S., Thourani, V.H., and Wechsler, A. S. (2000). "Surgical myocardial protection," in Cardiopulmonary Bypass: Principles and Practice, eds G. P. Gravlee, R. F. Davis, and J. R. Utley (Baltimore, MD, Philadelphia, PA: Lippincott, Williams and Wilkins), 214-264.
  • Wasserman, F., Wolcott, M.W., Wherrry, C.G., and Brodsky, L. (1959). Comparative effect of 5 percent potassium chloride and 30 percent potassium citrate in resuscitation from ventricular fibrillation following acute myocardial infarction; an experimental study. J. Thorac. Cardiovasc. Surg. 38, 30-39.
  • Weidmann, S. (1956). Shortening of the cardiac action potential due to a bried injection of KCl following onset of activity. J. Physiol. 132, 157-163.
  • Weirich, W.L. (1962). The effects of elective cardiac arrest on ventricular function. Prog. Cardiovasc. Dis. 4, 526-536 DOI: 10.1016/S0033-0620(62)80024-3
  • Weirich, W.L. (1962). The effects of elective cardiac arrest on ventricular function. Prog. Cardiovasc. Dis. 4, 526-536 DOI: 10.1016/S0033-0620(62)80024-3
  • Wiesenack, C., Liebold, A., Philipp, A., et al. Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 2004;28:1082-8.
  • Willman, V.L., Cooper, T., Zafiracopoulos, P., and Hanlon, C.R. (1959). Depression of ventricular function following elective cardiac arrest with potassium citrate. Surgery 46, 792-796.
  • Woodbury, L.A., Woodbury, J.W., and Hecht, H.H. (1950). Membrane resting and action potentials of single cardiac muscle fibers. Circulation 1, 264-266. doi: 10.11-61/01.CIR.1.2.264.
Еще
Статья